Compound information
- Natural Products
- ZC863604
- Molecular Formula
- C20H27N3O4S
- Molecular Weight
- 405.172227344 g/mol
- Structure
-
- IUPAC Name
- N-[4-[4-[(1S,6R)-norcarane-7-carbonyl]piperazin-1-yl]sulfonylphenyl]acetamide
- InChI
- InChI=1S/C20H27N3O4S/c1-14(24)21-15-6-8-16(9-7-15)28(26,27)23-12-10-22(11-13-23)20(25)19-17-4-2-3-5-18(17)19/h6-9,17-19H,2-5,10-13H2,1H3,(H,21,24)/t17-,18+,19+
- InChI Key
- GRMWLVUBEDYPPQ-BWTSREIZSA-N
- SMILES
- CC(=O)Nc1ccc(S(=O)(=O)N2CCN(C(=O)[C@@H]3[C@H]4CCCC[C@H]43)CC2)cc1
- Source
- ZINC000247918964
Warheads
- Cyclopropane
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 28 | Ring Count | 4 |
Heteroatom Count | 8 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 86.79 Å2 | LogP | 1.983 |
LogS | -3.599 | LogD | 2.117 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.01 | Pgp substrate | 0.765 |
HIA | 0.96 | F20 % | 0.995 |
F30 % | 0.885 | Caco-2 | -5.401 |
MDCK | -5.462 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.077 | PPB | 89.588 |
VD | 0.586 | Fu | 0.762 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.001 | CYP1A2 substrate | 0.52 |
CYP2A6 substrate | 0.561 | CYP2B6 substrate | 0.488 |
CYP2C19 inhibitor | 0.155 | CYP2C19 substrate | 0.862 |
CYP2C8 substrate | 0.59 | CYP2C9 inhibitor | 0.022 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.01 |
CYP2D6 substrate | 0.816 | CYP2E1 substrate | 0.963 |
CYP3A4 inhibitor | 0.017 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.241 | CL | 5.704 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.099 | Hepatotoxicity | 0.53 |
Mutagenicity | 0.026 | Rat Oral Acute Toxicity | 0.085 |
FDAMDD | 0.275 | Skin Sensitization | 0.007 |
Carcinogenicity | 0.118 | Eye Corrosion | 0.003 |
Eye Irritation | 0.198 | Respiratory Toxicity | 0.113 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.122 | IGC50 | 2.642 |
LC50FM | -10.919 | LC50DM | -2.213 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.271 | NR-AR-LBD | 0.248 |
NR-AhR | 0.037 | NR-Aromatase | 0.115 |
NR-ER | 0.361 | NR-ER-LBD | 0.59 |
NR-PPAR-gamma | 0.169 | SR-ARE | 0.567 |
SR-ATAD5 | 0.39 | SR-HSE | 0.126 |
SR-MMP | 0.029 | SR-p53 | 0.08 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.